-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang No.4 Pharmaceutical has been awarded the title of “Advanced Unit for Safe Production.”
Category:
Time：2020-06-04
Recently, the Office of the Shijiazhuang Municipal Committee for Work Safety issued a document announcing and commending the advanced units that achieved outstanding results in the 2019 work safety target management assessment. Shijiazhuang Sihua Pharmaceutical Co., Ltd. was awarded the title of “Advanced Unit for Work Safety in 2019.”
Recently, the Office of the Shijiazhuang Municipal Committee for Work Safety issued a document announcing and commending the advanced units that achieved outstanding results in the 2019 work safety target management assessment. Shijiazhuang No.4 Pharmaceutical Co., Ltd. was awarded the title of “Advanced Unit for Work Safety in 2019.”
Safe production is the very foundation upon which enterprises thrive. Over the years, Shijiazhuang No.4 Pharmaceutical has consistently adhered to the guiding principle of “safety first, prevention-oriented, and comprehensive management,” firmly upholding the red line that “development must never come at the cost of human life.” We have deeply embedded the concepts of “safety first,” “quality first,” and “zero accidents” into our corporate culture, placing safety at the top of our priorities. We continuously improve our safety production management system, solidly establishing a robust framework of responsibilities and regulations. We vigorously promote the construction of a dual preventive control mechanism—comprising hierarchical management of safety risks and systematic identification and remediation of potential hazards—and persistently advance the development of management systems and the standardization of safe production practices. We also carry out in-depth safety inspections and hazard identification and remediation activities, and steadily increase our investment in safe production.
In recent years, Shijiazhuang No.4 Pharmaceutical has achieved remarkable results in safe production and has successively earned such honors as “Hebei Province’s Advanced Unit for Emergency Management and Safe Production in 2019,” “Shijiazhuang City’s Model Enterprise for Safety Culture,” “Shijiazhuang City’s Pilot Enterprise for the Dual-Control Mechanism Construction,” and “Shijiazhuang High-Tech Zone’s Advanced Unit for Fire Safety Management.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license